UCNP@GA-FeIII probes acquire specific tumor-targeting ability by absorbing the unsaturated transferrin from serum that recognizes the overexpressed TfR1 on the surface of various solid, malignant tumor cells, including colorectal cancer cells LS180. This evidence concerns the gene TFRC and cancer.